B-50173 Question and Answer Document.pdf

This is a Question and Answer document issued by the Illinois Department of Central Management Services regarding Invitation for Bid (IFB) 26-416CMS-BOSS4-B-50173 for JPMC Mosquito Larvicide. The solicitation seeks mosquito larvicide products with the active ingredient Methoprene, available in multiple formulations including briquet, tablet, water-soluble pouch, or approved pre-packaged solid products with residual periods of up to 30 days or up to 150 days. Items 2 and 3 of the IFB are the subject of pricing inquiry clarification.

The document clarifies three key contractual matters: Business Enterprise Program (BEP) subcontractor utilization may meet or exceed the stated goal percentage, no adjustments to pricing outside those specified in the contract are permitted, and all allowable economic adjustments are detailed in Section 2.3 of the contract. Specifically, pricing adjustments are limited to Producer Price Index (PPI) adjustments as outlined in Section 2.3.2 and Governmental Actions adjustments as outlined in Section 2.3.4. No price escalators beyond these stipulated mechanisms are available. The document was issued on January 6, 2026, and addresses questions raised during the pre-bid conference call.